학술논문
Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer
Document Type
Erratum
Author
Roque, Dana M.; Siegel, Eric R.; Buza, Natalia; Bellone, Stefania; Silasi, Dan-Arin; Huang, Gloria S.; Andikyan, Vaagn; Clark, Mitchell; Azodi, Masoud; Schwartz, Peter E.; Rao, Gautam G.; Reader, Jocelyn C.; Hui, Pei; Tymon-Rosario, Joan R.; Harold, Justin; Mauricio, Dennis; Zeybek, Burak; Menderes, Gulden; Altwerger, Gary; Ratner, Elena; Santin, Alessandro D.
Source
British Journal of Cancer. 130(6):1073-1073
Subject
Language
English
ISSN
0007-0920
1532-1827
1532-1827